Skip to main content

New Australian Center Will Develop Therapies for Future Pandemics

Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.

Written byShawna Williams
| 2 min read
the Melbourne skyline with lake in foreground
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Australia’s largest-ever philanthropic donation for medical research will fund a new center dedicated to laying the groundwork for developing therapies to fight future pandemics, the Peter Doherty Institute for Infection and Immunity announced today (August 31). The new Cumming Global Centre for Pandemic Therapeutics (CGCPT) will be part of the Doherty Institute, which is a joint venture of the University of Melbourne and the Royal Melbourne Hospital. The newly announced center is named for Geoffrey Cumming, a businessman who lives in Melbourne and, according to Science, made his fortune in energy. He is contributing 250 million Australian dollars (US$172 million) to the center, while the state of Victoria is chipping in AU$75 million (US$51 million).

Cumming, who was born in Canada and holds Canadian and New Zealand citizenship, has made donations to medical research before, notes The Guardian, including a CA$100 million contribution to the University of Calgary in 2014. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo